RBC Capital Maintains Sector Perform on Bio-Techne, Lowers Price Target to $63

Benzinga · 4d ago
RBC Capital analyst Conor McNamara maintains Bio-Techne (NASDAQ:TECH) with a Sector Perform and lowers the price target from $72 to $63.